The Effect of Laughter Yoga on Patients With Ankylosing Spondylitis

Launched by ATATURK UNIVERSITY · Aug 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether laughter yoga can help people with ankylosing spondylitis (AS), a condition that mainly affects the spine and can cause pain and stiffness. The researchers want to see if laughter yoga can reduce disease symptoms, ease pain, improve daily functioning, lift mood, and enhance overall quality of life for those living with AS.

People who might join this study are adults diagnosed with ankylosing spondylitis who also experience some levels of depression, anxiety, or stress, based on specific questionnaire scores. Participants need to be able to hear and communicate well, have a smartphone, and be physically able to do yoga exercises safely. Those with certain health issues like recent surgery or serious conditions may not be eligible. If you join, you’ll take part in laughter yoga sessions and be monitored to see how it affects your symptoms and well-being. The study is not recruiting yet, but if you meet the criteria and are interested, this could be a way to explore a fun, non-drug approach to managing AS.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Those diagnosed with ankylosing spondylitis,
• • Those who scored 10 or above on the depression scale, 8 or above on the anxiety scale, and 15 or above on the stress scale of the Depression-Anxiety-Stress Scale
• • Are over 18 years of age,
• • Have no hearing or communication problems,
• • Possess a smartphone,
• • Have no physical problems that would prevent them from performing yoga exercises (bleeding hemorrhoids, any type of hernia, persistent cough, incontinence, hypertension, major psychiatric disorders, pregnancy, flu, epilepsy, or surgery within the last 3 months, etc.)
• • Ankylosing spondylitis patients who volunteer to participate in the study will be included in the study sample.
• Exclusion Criteria:
• • Patients who do not participate in laughter yoga
• • Patients who wish to withdraw from the study